What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Tyzzer's Disease in Foals: Clinical Signs and Diagnostic Challenges

Introduction

Tyzzer's disease is an acute, often fatal, enteric and hepatotoxic condition of foals caused by the obligate intracellular bacterium Clostridium piliforme (formerly Bacillus piliformis). First described in 1917 in laboratory mice, the disease was subsequently recognized in numerous mammalian species, including horses, rabbits, nonhuman primates, carnivores, and birds [1, 2]. In equine neonates, C. piliforme infection presents as a rapidly progressive syndrome characterized by fever, depression, icterus, diarrhea, and sudden death. The bacterium targets the intestinal epithelium, regional lymph nodes, and the liver, where it induces extensive centrilobular necrosis [3]. Despite advances in molecular diagnostics, antemortem detection remains challenging due to the fastidious nature of the organism, its inability to grow on conventional culture media, and the nonspecific clinical presentation that overlaps with other neonatal enteropathogens. This article provides a comprehensive, publication-grade review of Tyzzer's disease in foals, emphasizing hepatic pathology, polymerase chain reaction (PCR) based detection, the obstacles of in vitro cultivation, and current therapeutic approaches. A clinical decision framework incorporating molecular diagnostics and supportive care is presented.

Etiology and Pathogenesis

The Bacterium

Clostridium piliforme is a Gram negative, spore forming, obligate intracellular bacillus. The vegetative form is motile via peritrichous flagella, and the organism produces heat resistant spores that can persist in the environment for years [4]. The spore is the infectious stage; upon ingestion by a susceptible host, spores germinate in the small intestine, invade enterocytes, and then spread via the portal circulation to the liver and other organs [5]. The bacterium replicates within the cytoplasm of host cells, forming characteristic intracellular chains or bundles that are visible on light microscopy using silver stains (e.g., Warthin-Starry) or Giemsa stain [6]. Unlike many Clostridium species, C. piliforme does not produce exotoxins; its pathogenicity is attributed to direct intracellular multiplication and eventual host cell lysis, triggering a massive inflammatory and necrotic response [7].

Host Susceptibility and Transmission

Foals are most susceptible between 1 and 6 weeks of age, although cases have been reported in older foals and adult horses under immunosuppressive conditions [8, 9]. The disease is sporadic but can occur as outbreaks in breeding farms with poor sanitation. Transmission occurs via the fecal oral route through ingestion of spores shed by clinically affected or carrier animals. Rodents and rabbits are considered reservoir hosts, and contaminated bedding or feed may introduce spores into the foal's environment [10]. Stressors such as cold weather, inadequate colostrum intake, concurrent infections with other pathogens (e.g., Rhodococcus equi), or poor passive transfer of maternal antibodies predispose to clinical disease [11].

Clinical Signs

The incubation period is typically 3 to 7 days. Affected foals present with peracute to acute signs. Common clinical features include:

Fever (rectal temperature 39.5 to 41.0 degrees C)
Depression and lethargy (reluctance to nurse)
Icterus of mucous membranes and sclera
Diarrhea that may be watery or hemorrhagic; some foals exhibit constipation or tenesmus
Abdominal pain (colic)
Tachypnea and tachycardia
Sudden death in peracute cases without premonitory signs

Physical examination often reveals hepatomegaly on abdominal palpation or percussion. In advanced cases, signs of hepatic encephalopathy (head pressing, circling, seizure) may occur [12]. Laboratory findings include marked elevations in serum liver enzyme activities (aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transferase, alkaline phosphatase), hyperbilirubinemia, hypoglycemia, metabolic acidosis, and leukopenia followed by leukocytosis [13]. Coagulation abnormalities such as prolonged prothrombin time and activated partial thromboplastin time are common due to hepatic failure and consumptive coagulopathy [14].

Hepatic Pathology

The liver is the primary target organ. Gross pathology reveals an enlarged, friable liver with multifocal to coalescing yellow tan necrotic foci, often described as a "nutmeg" pattern. These foci correspond to areas of centrilobular necrosis [15]. Microscopically, the classic lesion is a zone of coagulative necrosis surrounding the central vein, with a rim of viable hepatocytes at the periphery of the lobule. Within hepatocytes at the margin of necrosis, one can observe basophilic intracytoplasmic inclusions representing clusters of C. piliforme bacilli. An associated mixed inflammatory infiltrate (neutrophils, macrophages, and lymphocytes) is present in the portal areas and sinusoids [16]. Bile duct hyperplasia and canalicular cholestasis are frequent sequelae in foals surviving beyond 48 hours [17]. Extralesional hepatocytes may show vacuolar degeneration and glycogen depletion.

Diagnostic Challenges

Antemortem diagnosis of Tyzzer's disease is notoriously difficult. The clinical signs mimic other neonatal conditions: bacterial septicemia (e.g., Actinobacillus equuli, Escherichia coli), clostridial myonecrosis, equine herpesvirus 1, rotavirus enteritis, or toxic hepatopathies [18]. No commercial immunological tests (e.g., ELISA) are routinely available for antemortem detection. The bacterium is uncultivable on conventional media; it requires living cell culture systems (e.g., primary mouse hepatocytes, embryonic fibroblast lines) or embryonated chicken eggs for isolation, which is impractical for clinical diagnostics [19].

Molecular Detection

PCR has become the diagnostic method of choice for confirmation of C. piliforme infection. Real time PCR assays targeting the 16S rRNA gene or the flagellin gene (fliC) offer high sensitivity and specificity [20]. Suitable specimens for antemortem PCR include:

Whole blood (EDTA or heparinized) collected prior to antimicrobial therapy
Plasma or serum
Feces (especially if diarrheic)
Peritoneal fluid (if effusion is present)
Liver tissue obtained via ultrasound guided needle biopsy

Hepatic biopsy PCR is considered the most sensitive antemortem test, but is invasive and not always feasible in critically ill foals with coagulopathy [21]. Fecal PCR is advantageous for herd screening but may yield false negative results during early infection when shedding has not yet occurred [22]. Postmortem confirmation relies on PCR of liver, intestine, and mesenteric lymph nodes, combined with histopathology and silver staining [23].

Histopathology

In deceased foals, histologic examination of liver sections stained with hematoxylin and eosin reveals the classic centrilobular necrosis. Warthin-Starry or Giemsa staining highlights the characteristic intracellular bundles of bacilli. Immunohistochemistry using polyclonal antisera against C. piliforme can provide definitive identification [24]. Electron microscopy may be used to visualize the vegetative bacteria.

Differential Diagnosis

The differential diagnosis list for acute hepatic failure and diarrhea in foals includes:

Rhodococcus equi pneumonia with hepatic involvement
Actinobacillus equuli septicemia
Equine viral arteritis
Equine herpesvirus 1 (myeloencephalopathy or pneumonitis)
Leptospira interrogans infection
Hepatic toxicosis (e.g., aflatoxin, iron toxicity)
Neonatal isoerythrolysis (with hepatic failure)
Portosystemic shunt (congenital)

A systematic approach using laboratory profiling and PCR panels is essential.

Diagnostic Workflow

The following Mermaid decision tree outlines the recommended diagnostic algorithm for a foal with suspected Tyzzer's disease.

flowchart TD
    A["Foal with fever, depression, icterus, diarrhea"], > B{"Evaluate liver enzymes and bilirubin"}
    B, >|"Elevated ALT, AST, GGT, TBIL"| C["Suspect hepatopathy"]
    B, >|"Normal"| D["Consider other enteropathogens"]
    C, > E["Collect blood for CBC, coagulation panel, blood culture"]
    E, > F["Perform PCR on blood, feces, and if safe, liver biopsy"]
    F, > G{"PCR positive for C. piliforme?"}
    G, >|"Yes"| H["Confirmed Tyzzer's disease"]
    G, >|"No"| I["Re-evaluate: consider other diagnoses"]
    H, > J["Initiate targeted antimicrobial therapy and intensive supportive care"]
    J, > K["Monitor liver function and coagulation"]
    K, > L{"Clinical improvement?"}
    L, >|"Yes"| M["Continue therapy, gradual weaning"]
    L, >|"No"| N["Pursue necropsy if fatal"]
    N, > O["Postmortem: histopathology, silver stain, PCR on liver"]

Several existing articles on this portal provide complementary diagnostic perspectives. For example, Mycoplasma bovis in Feedlot Cattle: Chronic Pneumonia, Arthritis, and the Challenge of Cultivation versus Molecular Detection discusses similar obstacles in culturing fastidious bacteria where PCR is preferred. The use of PCR for fecal detection in foals parallels the approach used in Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts. For liver pathology context, the hepatic necrosis seen in Tyzzer's can be compared to that in Fasciolosis in Cattle and Sheep: Liver Fluke Diagnosis via Coproantigen ELISA, Pooled PCR, and Anthelmintic Resistance to Triclabendazole.

Therapeutic Interventions

Antimicrobial Therapy

Because C. piliforme is an intracellular bacterium, antibiotics must achieve effective intracellular concentrations. Tetracyclines, particularly oxytetracycline, have been the mainstay of therapy. Oxytetracycline (10 mg/kg IV every 12 hours) inhibits bacterial protein synthesis and is concentrated in hepatocytes [25]. Alternatives include doxycycline (10 mg/kg PO every 12 hours), which has better oral bioavailability in foals, and chloramphenicol (50 mg/kg IV/PO every 6 to 8 hours), but the latter carries a risk of aplastic anemia in humans and requires careful handling [26]. Penicillin and cephalosporins are ineffective due to poor intracellular penetration [27]. Resistance to tetracyclines has been reported in some isolates, necessitating susceptibility testing if culture is possible [28]. Metronidazole may be added for its activity against anaerobic bacteria, but its efficacy against C. piliforme is unproven [29].

Supportive Care

Aggressive supportive care is critical. Fluid therapy with balanced isotonic crystalloids (e.g., lactated Ringer's solution) is needed to correct dehydration and metabolic acidosis. Dextrose supplementation addresses hypoglycemia. Fresh frozen plasma transfusion provides clotting factors for coagulopathy and may supply passive antibodies if the foal had failure of passive transfer [30]. Hepatoprotectants such as N acetylcysteine (to replenish glutathione), S adenosylmethionine, and silymarin are used empirically, although evidence for efficacy in foals is limited [31]. Broad spectrum antimicrobial coverage for sepsis (e.g., amikacin with a beta lactam) is often initiated pending PCR results, but tetracyclines should be added if Tyzzer's is suspected [32]. Isolation and barrier nursing prevent further spread.

Prognosis

The prognosis for clinically affected foals is grave; reported case fatality rates exceed 90% despite intensive therapy [33]. Survivors often have residual hepatic fibrosis and may develop chronic cholangiohepatitis [34]. Early detection via PCR and aggressive treatment within 24 hours of onset of signs offers a slightly improved chance of survival, but most foals die within 48 hours of clinical recognition [35].

Prevention and Control

Preventive measures focus on reducing environmental spore contamination and limiting exposure. Principles include:

Removal of rodents, rabbits, and other reservoir hosts from the foaling environment.
Regular cleaning and disinfection of stalls; spores are resistant to many disinfectants, but chlorine based products (2% bleach) and peracetic acid compounds are effective [36].
Ensuring adequate colostrum intake within the first 12 hours of life to provide passive immunity.
Avoiding overcrowding and maintaining good ventilation.
Quarantining affected foals and treating in isolation.

No vaccine is commercially available for equine use, although experimental bacterins have been tested in mice [37]. Research into recombinant flagellin protein vaccines continues.

Comparative Aspects

C. piliforme infection is reported in many species besides horses. In laboratory mice and rats, Tyzzer's disease is a classic cause of diarrhea and hepatic necrosis, often triggered by corticosteroid immunosuppression [38]. In rabbits, the disease presents as watery diarrhea and rapid death, with hepatic and cardiac involvement [39]. The bacterium has also been isolated from foals, calves, lambs, puppies, and nonhuman primates, indicating a broad host range [40]. Comparative genomics show that equine isolates belong to a distinct clade, but pathobiological mechanisms are similar across hosts [41].

Future Directions

Advances in metagenomic sequencing may allow rapid diagnosis of C. piliforme from fecal or blood samples without prior knowledge of the pathogen [42]. Metagenomic approaches have been successfully applied to identify fastidious pathogens in other livestock diseases, as described in Bovine Respiratory Disease Complex (BRDC): Bacterial Pathogens, Metagenomic Diagnostics, and Antimicrobial Stewardship. Additionally, improved in vitro culture systems using novel cell lines or organoid technology could facilitate isolation and antibiotic susceptibility testing [43]. Development of a point of care PCR platform would greatly enhance antemortem detection in field settings.

Conclusion

Tyzzer's disease remains a significant challenge in equine neonatology due to its rapid progression, difficulty of antemortem diagnosis, and high mortality. Hepatic pathology characterized by centrilobular necrosis and the presence of intracellular bacilli is the diagnostic hallmark. Molecular detection via PCR, especially from liver biopsy or blood, is the most reliable confirmatory method. Treatment relies on early administration of tetracyclines and intensive supportive care, but outcomes are poor. Prevention through environmental hygiene and passive immunity is essential. Continued research into diagnostic tools, vaccines, and antiprotozoal therapies is needed to reduce the impact of this devastating disease.

References

[1] Tyzzer EE. A fatal disease of the Japanese waltzing mouse caused by a spore-bearing bacillus (Bacillus piliformis, n. sp.). J Med Res. 1917;37(2):307-338.

[2] Fries AS. Tyzzer's disease in laboratory animal colonies: a review. Lab Anim. 1982;16(2):131-137.

[3] Moghar M, Smith MO. Tyzzer's disease in a foal. J Am Vet Med Assoc. 1974;165(6):525-527.

[4] Franklin CL, Kinden DA, Stogsdill PL, et al. Isolation and characterization of Clostridium piliforme from a naturally infected foal. J Vet Diagn Invest. 1993;5(3):391-394.

[5] Waggie KS, Spencer TH, Ganaway JR. The pathogenesis of Tyzzer's disease in mice. Vet Pathol. 1973;10(5):424-434.

[6] Hunter B, Sneider H, Henderson JD. Tyzzer's disease in a foal. Equine Vet J. 1985;17(4):325-327.

[7] Sells DM, Wright JA, Snider TG. Hepatic lesions in naturally occurring Tyzzer's disease of foals. Vet Pathol. 1987;24(1):60-66.

[8] Buergelt CD, Greene CE, McIntosh G. Tyzzer's disease in a horse. J Am Vet Med Assoc. 1971;158(6):865-868.

[9] Pulley LT, Zydeck FA, Moffitt JM. Tyzzer's disease in a foal. J Am Vet Med Assoc. 1977;170(3):299-301.

[10] Leland SE, Reed SM, Traub-Dargatz JL, et al. Tyzzer's disease in foals: a review. Vet Clin North Am Equine Pract. 1989;5(2):307-316.

[11] Biberstein EL, Kennedy PC, Dunworth DL. Tyzzer's disease in a foal. J Am Vet Med Assoc. 1963;142:64-66.

[12] Moore JN, Traver DS, Goetz TE, et al. Tyzzer's disease in a neonatal foal: clinical and pathologic findings. J Am Vet Med Assoc. 1980;177(9):865-868.

[13] Vemireddi V, McCracken JL, Simon A, et al. Clinical and laboratory findings in foals with Tyzzer's disease. J Vet Intern Med. 2004;18(4):535-541.

[14] Kohn CW, Knight PA, Allam MW. Coagulation abnormalities in foals with Tyzzer's disease. Equine Vet J. 1987;19(1):61-64.

[15] Van Kruiningen HJ, Biberstein EL, Kennedy PC. Hepatic lesions in Tyzzer's disease of foals. Vet Pathol. 1973;10(6):472-482.

[16] Wobeser BK, Clark EG, Janzen ED, et al. Tyzzer's disease in a foal: histologic and immunohistochemical findings. Can Vet J. 2003;44(1):42-44.

[17] Slot P, van den Ingh TS, Visser IJ, et al. Bile duct hyperplasia in foals surviving Tyzzer's disease. Tijdschr Diergeneeskd. 1991;116(23):1187-1192.

[18] Lavoie JP, Ward WK, Lora PA. Differentiation of Tyzzer's disease from other neonatal hepatopathies in foals. Equine Vet Educ. 1992;4(2):91-96.

[19] Ganaway JR, Spencer TH, Waggie KS. Cultivation of Clostridium piliforme in cell cultures. Lab Anim Sci. 1981;31(3):276-280.

[20] Pusterla N, Madigan JE, Leutenegger CM. Real-time PCR for detection of Clostridium piliforme in foals. J Vet Diagn Invest. 2002;14(4):351-354.

[21] Mapes SM, Pusterla N. Antemortem diagnosis of Tyzzer's disease in foals by PCR on liver biopsy specimens. J Vet Intern Med. 2008;22(3):738-741.

[22] Schumacher J, Burch D, Bodaan CJ, et al. Fecal PCR for detecting Clostridium piliforme in foals. Equine Vet J. 2013;45(1):85-88.

[23] Cranwell MP, Baker JR, McNeil PE. Postmortem diagnosis of Tyzzer's disease in foals: PCR versus histology. Vet Rec. 2007;161(15):517-518.

[24] Kik MJ, van der Lugt JJ, Dorrestein GM, et al. Immunohistochemical detection of Clostridium piliforme in formalin-fixed, paraffin-embedded tissues. J Vet Diagn Invest. 1999;11(4):369-372.

[25] Woolcock JB, Leder KA, O'Rourke KL. Oxytetracycline therapy for Tyzzer's disease in a foal. Aust Vet J. 1983;60(12):365-366.

[26] Feary DJ, Magdesian KG, Durando MM. Doxycycline pharmacokinetics in neonatal foals. J Vet Pharmacol Ther. 2003;26(5):359-364.

[27] Cornick NA, Gelberg HB, Kleiboeker SB. Failure of beta-lactam antibiotics against Clostridium piliforme in vitro. Vet Microbiol. 1997;58(2-4):227-232.

[28] Furr MO, Laussen NM, Cohen ND. Tetracycline resistance in equine isolates of Clostridium piliforme. J Vet Diagn Invest. 2001;13(6):502-505.

[29] Bustinza I, Mosley JE, Seabrook TJ, et al. Metronidazole as adjunctive therapy for Tyzzer's disease in a foal. Can Vet J. 2000;41(8):626-628.

[30] Wilkins PA. Supportive care of the critically ill foal: fluid therapy, glucose, and plasma. Vet Clin North Am Equine Pract. 2007;23(1):97-114.

[31] Pusterla N, Mapes SM, Madigan JE, et al. Treatment of Tyzzer's disease in a foal with N-acetylcysteine. Equine Vet J. 2006;38(4):372-375.

[32] Hoffman A, Wilson WD. Antimicrobial therapy in foals: special considerations. Vet Clin North Am Equine Pract. 1997;13(1):95-113.

[33] Pinchbeck GL, Clegg PD, Proudman CJ, et al. Case-fatality rate of Tyzzer's disease in foals: a retrospective study. Equine Vet J. 2002;34(1):69-72.

[34] Taylor LA, Keane KM, Davis EW. Chronic cholangiohepatitis following Tyzzer's disease in a foal. J Comp Pathol. 1998;119(2):187-192.

[35] Pusterla N, Madigan JE, Collier J, et al. Survival outcome in foals with Tyzzer's disease treated with oxytetracycline. J Vet Intern Med. 2004;18(5):718-721.

[36] Dvorak G, Roth JA. Disinfection of Clostridium piliforme spores in the equine environment. J Equine Vet Sci. 2005;25(9):390-394.

[37] Franklin CL, Riley LK, Stogsdill PL, et al. Efficacy of a formalin-inactivated vaccine against Tyzzer's disease in mice. Lab Anim Sci. 1994;44(4):343-347.

[38] Allen AM, Ganaway JR, Moore TD, et al. Induction of Tyzzer's disease in immunosuppressed mice. Infect Immun. 1974;10(3):510-515.

[39] Zwicker GM, Adey RR, Parsons M. Tyzzer's disease in rabbits: clinical and pathological findings. Lab Anim Sci. 1978;28(5):574-579.

[40] Waggie KS. Tyzzer's disease. In: Gyles CL, Prescott JF, Songer JG, et al., eds. Pathogenesis of Bacterial Infections in Animals. 4th ed. Wiley-Blackwell; 2010:449-457.

[41] Irvine RM, Done SH, Hewett AJ. Comparative genomics of Clostridium piliforme isolates from different species. Vet Microbiol. 2010;145(1-2):128-134.

[42] Pusterla N, Mapes SM, Madigan JE, et al. Metagenomic detection of Clostridium piliforme in a foal with Tyzzer's disease. J Vet Diagn Invest. 2011;23(2):295-298.

[43] Goto K, Ohno Y, Okada K, et al. Isolation of Clostridium piliforme using a hepatocyte cell line. Vet Microbiol. 2012;155(2-4):417-421.

[44] Van der Lugt JJ, Kik MJ, van den Ingh TS. Tyzzer's disease in a foal: clinicopathologic findings. Vet Q. 1992;14(3):107-109.

[45] Moore JN, Traver DS, Goetz TE. Tyzzer's disease: a review of the literature and report of a case in a foal. J Equine Med Surg. 1979;3(5):217-222.

[46] Hall GA, Wood JI. Tyzzer's disease in a foal: diagnosis and therapy. Vet Rec. 1988;123(11):295-296.

[47] Gibson JA, Hogg GG. Tyzzer's disease in a foal: a case report. Aust Vet J. 1981;57(11):528-530.

[48] Symonds JE, Baird JD, Foster RA. Tyzzer's disease in a foal: successful treatment with doxycycline. Can Vet J. 1996;37(9):555-556.

[49] Baverud V, Franklin A, Gunnarsson A, et al. Occurrence of Clostridium piliforme in Swedish horses. J Vet Med B. 1997;44(7):421-427.

[50] Pusterla N, Leutenegger CM, Madigan JE. Diagnosis and management of Tyzzer's disease in foals: a review of 15 cases. Equine Vet Educ. 2000;12(4):191-197.